MedTrace Logo

Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2

NCT03815305 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2019-01-24

No results posted yet for this study

Summary

The objective of this study is to evaluate the effect of Centella asiatica on hydration status of lower leg skin of DM type 2 patients by measuring SRRC and Skin Capacitance in correlation with AGEs CML, inflammation marker IL-1α, and oxidative stress SOD in stratum corneum.

Conditions

  • Xerosis Cutis
  • Diabetes Mellitus, Type 2

Interventions

DRUG

Centella Asiatica Extract

centlla asiatica oral drug at 1100 mg dose

DRUG

Topical CA

1% centella asiatica ointment

DRUG

Petroleum jelly

vaseline album

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Suhendro Suhendro, Doctor · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-30
Primary Completion
2019-01-12
Completion
2019-06-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03815305 on ClinicalTrials.gov